Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MULTIPLE SCLEROSIS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07831239
What this trial is testing

Association Between Peripheral Immune Biomarkers and Functional Performance in Multiple Sclerosis

Who this might be right for
MS (Multiple Sclerosis)
Halic University 20
Testing effectiveness (Phase 2)Study completedNCT02284568
What this trial is testing

Clinical Study in Subjects With Primary Progressive Multiple Sclerosis to Assess the Efficacy, Safety and Tolerability of Two Oral Doses of Laquinimod Either of 0.6 mg/Day or 1.5mg/Day (Experimental Drug) as Compared to Placebo

Who this might be right for
Primary Progressive Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 374
Not applicableLooking for participantsNCT06341023
What this trial is testing

Functional Balance Intervention in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University of Illinois at Chicago 120
Large-scale testing (Phase 3)Study completedNCT00473213
What this trial is testing

Optimizing IFN Beta - 1B Dose

Who this might be right for
Multiple Sclerosis
University of Turin, Italy 217
Testing effectiveness (Phase 2)Study completedNCT01285401
What this trial is testing

Supplementation of VigantOL® Oil Versus Placebo as Add-on in Patients With Relapsing Remitting Multiple Sclerosis Receiving Rebif® Treatment

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Merck KGaA, Darmstadt, Germany 260
Not applicableActive Not RecruitingNCT03134716
What this trial is testing

Role of Microglia in the Pathogenesis of Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Turku University Hospital 35
Large-scale testing (Phase 3)Study completedNCT02634931
What this trial is testing

Long-term Trial of Topical Sirolimus to Angiofibroma in Patient With Tuberous Sclerosis Complex

Who this might be right for
Tuberous SclerosisAngiofibromaHypomelanotic Macule+1 more
Nobelpharma 94
Not applicableEnrolling By InvitationNCT03032601
What this trial is testing

Physiological Effects of N-Acetyl Cysteine in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Thomas Jefferson University 55
Testing effectiveness (Phase 2)Active Not RecruitingNCT06800404
What this trial is testing

"HB-adMSCs for the Treatment of Patients With Multiple Sclerosis"

Who this might be right for
Relapsing Remitting Multiple Sclerosis (RRMS)Multiple Sclerosis
Hope Biosciences Research Foundation 10
Not applicableStudy completedNCT05352971
What this trial is testing

Validation of Ella Platform for Serum Nfl And GFAP Measures In Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis
Centre Hospitalier Universitaire de Nīmes 664
Large-scale testing (Phase 3)Ended earlyNCT04203498
What this trial is testing

Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS)
Jazz Pharmaceuticals 139
Not applicableStudy completedNCT04239521
What this trial is testing

The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata

Who this might be right for
Alopecia AreataDepressive EpisodeRecurrent Depressive Disorder+33 more
Momentum Data 51,955
Not applicableStudy completedNCT03499314
What this trial is testing

A Pilot Trial of Remotely-Supervised Transcranial Direct Current Stimulation (RS-tDCS) to Enhance Motor Learning in Progressive Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
NYU Langone Health 65
Post-approval studies (Phase 4)Looking for participantsNCT07087106
What this trial is testing

Glucose Consumption in MS Using [F-18]FDG-PET

Who this might be right for
Multiple Sclerosis
Brigham and Women's Hospital 50
Not applicableStudy completedNCT04125628
What this trial is testing

Exercise on Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis
Petros Dinas 10
Not applicableUnknownNCT04236544
What this trial is testing

Patient Experiences of Multiple Sclerosis (PExMS)

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingPatient Engagement+1 more
Universitätsklinikum Hamburg-Eppendorf 55
Early research (Phase 1)Ended earlyNCT01435993
What this trial is testing

Multiple Doses of Anti-NOGO A in Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
GlaxoSmithKline 3
Large-scale testing (Phase 3)Study completedNCT04626921
What this trial is testing

A Multi-Center, Open-Label Long-Term Extension Study of CNM-Au8 In Patients With Stable Relapsing Multiple Sclerosis

Who this might be right for
Relapsing Multiple Sclerosis
Clene Nanomedicine 55
Large-scale testing (Phase 3)Ended earlyNCT04485104
What this trial is testing

Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures

Who this might be right for
Seizure in Participants With Tuberous Sclerosis ComplexSeizure in Participants With Dravet SyndromeSeizure in Participants With Lennox-Gastaut Syndrome
Jazz Pharmaceuticals 3
Not applicableStudy completedNCT00884481
What this trial is testing

Effects of Tysabri (BG00002) Over 12 Months on MS Related Fatigue in Participants With RRMS

Who this might be right for
Relapsing-Remitting Multiple SclerosisFatigue
Biogen 195
Next Page